1. Home
  2. CPRX vs GPOR Comparison

CPRX vs GPOR Comparison

Compare CPRX & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • GPOR
  • Stock Information
  • Founded
  • CPRX 2002
  • GPOR 1997
  • Country
  • CPRX United States
  • GPOR United States
  • Employees
  • CPRX N/A
  • GPOR N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • GPOR Oil & Gas Production
  • Sector
  • CPRX Health Care
  • GPOR Energy
  • Exchange
  • CPRX Nasdaq
  • GPOR Nasdaq
  • Market Cap
  • CPRX 2.8B
  • GPOR 2.7B
  • IPO Year
  • CPRX 2006
  • GPOR N/A
  • Fundamental
  • Price
  • CPRX $20.60
  • GPOR $159.81
  • Analyst Decision
  • CPRX Strong Buy
  • GPOR Buy
  • Analyst Count
  • CPRX 6
  • GPOR 7
  • Target Price
  • CPRX $30.50
  • GPOR $179.33
  • AVG Volume (30 Days)
  • CPRX 984.3K
  • GPOR 217.5K
  • Earning Date
  • CPRX 11-06-2024
  • GPOR 11-05-2024
  • Dividend Yield
  • CPRX N/A
  • GPOR N/A
  • EPS Growth
  • CPRX 114.68
  • GPOR N/A
  • EPS
  • CPRX 1.18
  • GPOR 11.88
  • Revenue
  • CPRX $460,482,000.00
  • GPOR $886,642,000.00
  • Revenue This Year
  • CPRX $21.99
  • GPOR $5.77
  • Revenue Next Year
  • CPRX $17.95
  • GPOR $25.53
  • P/E Ratio
  • CPRX $17.48
  • GPOR $13.44
  • Revenue Growth
  • CPRX 32.17
  • GPOR N/A
  • 52 Week Low
  • CPRX $13.00
  • GPOR $119.75
  • 52 Week High
  • CPRX $24.27
  • GPOR $166.48
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 39.71
  • GPOR 64.18
  • Support Level
  • CPRX $21.30
  • GPOR $151.32
  • Resistance Level
  • CPRX $24.27
  • GPOR $166.48
  • Average True Range (ATR)
  • CPRX 0.79
  • GPOR 4.13
  • MACD
  • CPRX -0.18
  • GPOR 1.89
  • Stochastic Oscillator
  • CPRX 4.18
  • GPOR 77.77

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition and production of natural gas, crude oil and NGL in the United States. It operates through Utica Shale and Scoop properties. The Utica Shale is located in the Appalachian Basin of the United States and Canada. The Scoop (South Central Oklahoma Oil Province) play of Oklahoma is located in the southeast portion of the prolific Anadarko Basin.

Share on Social Networks: